[{"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-001", "question": "A 34-year-old woman at 32 weeks gestation presents with hemodynamic instability after sudden right upper quadrant pain. CT angiography demonstrates rupture of a 12 cm hepatic hemangioma with active extravasation and consumptive coagulopathy (platelets 45,000, INR 2.3). What is the definitive management strategy that optimizes maternal-fetal survival?", "options": ["A) Emergency cesarean section followed by immediate right hepatectomy", "B) Immediate exploratory laparotomy with hepatic artery ligation and packing", "C) Hepatic artery embolization with gelatin sponge, delayed cesarean section at 34 weeks", "D) Emergent cesarean section with concurrent hepatic artery embolization in hybrid OR", "E) Staged approach: hepatic artery embolization first, then cesarean section once coagulopathy corrects"], "answer": "E", "answer_index": 4, "explanation": "In third-trimester ruptured giant hepatic hemangioma with Kasabach-Merritt phenomenon, staged management with hepatic artery embolization first to control bleeding and reverse coagulopathy, followed by semi-elective cesarean section, yields superior maternal-fetal outcomes compared to simultaneous or surgery-first approaches. Embolization with gelatin sponge preserves future liver function while controlling hemorrhage.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: 32‑week viable gestation, hemodynamic instability, CT‑proven active extravasation from a giant hepatic hemangioma, and severe consumptive coagulopathy (platelets 45 000, INR 2.3). These findings point to a ruptured hemangioma with Kasabach‑Merritt phenomenon in a pregnant patient. The optimal strategy is to first control hemorrhage and reverse coagulopathy via hepatic artery embolization, then deliver once the mother is stable—exactly what option E describes. Options A and B impose major surgery in an unstable, coagulopathic patient and risk maternal death. Option C locks cesarean timing to 34 weeks regardless of maternal status, which may be unsafe. Option D combines two high‑risk procedures simultaneously, adding unnecessary complexity. No internal contradictions exist; the vignette supplies sufficient discriminators to identify a single best answer. Medical accuracy: current literature supports staged embolization followed by semi‑elective cesarean as the maternal‑fetal survival‑maximizing approach; gelatin‑sponge embolization preserves liver parenchyma and is the standard of care. No factual errors. Minimal fix: add one line stating 'fetal heart rate tracing is reassuring' to remove any ambiguity about immediate delivery, though the item remains defensible without it.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: 32‑week viable gestation, hemodynamic instability, CT‑proven active extravasation from a giant hepatic hemangioma, and severe consumptive coagulopathy (platelets 45 000, INR 2.3). These findings point to a ruptured hemangioma with Kasabach‑Merritt phenomenon in a pregnant patient. The optimal strategy is to first control hemorrhage and reverse coagulopathy via hepatic artery embolization, then deliver once the mother is stable—exactly what option E describes. Options A and B impose major surgery in an unstable, coagulopathic patient and risk maternal death. Option C locks cesarean timing to 34 weeks regardless of maternal status, which may be unsafe. Option D combines two high‑risk procedures simultaneously, adding unnecessary complexity. No internal contradictions exist; the vignette supplies sufficient discriminators to identify a single best answer. Medical accuracy: current literature supports staged embolization followed by semi‑elective cesarean as the maternal‑fetal survival‑maximizing approach; gelatin‑sponge embolization preserves liver parenchyma and is the standard of care. No factual errors. Minimal fix: add one line stating 'fetal heart rate tracing is reassuring' to remove any ambiguity about immediate delivery, though the item remains defensible without it.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-002", "question": "A 68-year-old man with end colostomy presents with a 6 cm parastomal hernia and 8 cm prolapse through the fascial defect. He has failed conservative management with hernia belt. What is the optimal surgical repair technique and mesh configuration?", "options": ["A) Laparoscopic keyhole repair with heavyweight polypropylene mesh", "B) Open Sugarbaker repair with lightweight macroporous polypropylene mesh", "C) Laparoscopic modified Sugarbaker with dual-layer composite mesh (ePTFE/polypropylene)", "D) Open keyhole repair with biologic mesh (porcine dermis)", "E) Laparoscopic sandwich repair with two lightweight polypropylene meshes"], "answer": "B", "answer_index": 1, "explanation": "For parastomal hernia with significant prolapse, open Sugarbaker repair with lightweight macroporous polypropylene mesh provides superior recurrence prevention while allowing parastomal bowel mobility. The Sugarbaker configuration prevents mesh erosion by avoiding circumferential stoma encirclement, and lightweight mesh reduces infection risk in contaminated fields compared to composite or biologic meshes.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 6 cm parastomal hernia, 8 cm prolapse through fascial defect, failed conservative management with hernia belt, end colostomy (contaminated field). Main logical issue(s): None. Main medical accuracy issue(s): None. Minimal fix: No edit needed. The stem presents a 68-year-old man with a large parastomal hernia and prolapse after failed conservative therapy. The optimal repair is open Sugarbaker with lightweight macroporous polypropylene mesh, which avoids circumferential encirclement, reduces erosion and recurrence, and lowers infection risk in a contaminated field. Alternative options are inferior: laparoscopic keyhole (higher erosion/recurrence, heavyweight mesh infection risk), laparoscopic modified Sugarbaker with composite mesh (composite barrier infection risk), open keyhole with biologic mesh (keyhole erosion, biologic high cost/recurrence), laparoscopic sandwich (less suitable for large prolapse). No contradictions; stem provides sufficient detail for a single best answer. Medical accuracy aligns with current hernia society guidelines for this patient.\",\n\"medical_accuracy_score\":  \t\t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: 6 cm parastomal hernia, 8 cm prolapse through fascial defect, failed conservative management with hernia belt, end colostomy (contaminated field). Main logical issue(s): None. Main medical accuracy issue(s): None. Minimal fix: No edit needed. The stem presents a 68-year-old man with a large parastomal hernia and prolapse after failed conservative therapy. The optimal repair is open Sugarbaker with lightweight macroporous polypropylene mesh, which avoids circumferential encirclement, reduces erosion and recurrence, and lowers infection risk in a contaminated field. Alternative options are inferior: laparoscopic keyhole (higher erosion/recurrence, heavyweight mesh infection risk), laparoscopic modified Sugarbaker with composite mesh (composite barrier infection risk), open keyhole with biologic mesh (keyhole erosion, biologic high cost/recurrence), laparoscopic sandwich (less suitable for large prolapse). No contradictions; stem provides sufficient detail for a single best answer. Medical accuracy aligns with current hernia society guidelines for this patient.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-003", "question": "A 3-year-old child with bilateral retinoblastoma has persistent class 3 vitreous seeds (vitreous clouds) in the right eye after six cycles of systemic chemotherapy and three intravitreal melphalan injections (30 µg). Examination shows tumor regression but diffuse non-confluent vitreous opacities. What is the next definitive management step?", "options": ["A) Increase intravitreal melphalan dose to 50 µg weekly for three doses", "B) Plaque brachytherapy with 125I to deliver 40 Gy to vitreous base", "C) Enucleation with histopathologic risk factor assessment", "D) Intravitreal topotecan 20 µg alternating with melphalan every 2 weeks", "E) External beam radiation therapy 45 Gy to entire globe"], "answer": "D", "answer_index": 3, "explanation": "For persistent class 3 vitreous seeds after standard melphalan, alternating intravitreal topotecan with melphalan provides synergistic tumoricidal activity while avoiding retinal toxicity from dose escalation. This protocol achieves 85% globe salvage for refractory seeds compared to 40% with continued melphalan alone, and avoids the late effects of external beam radiation in hereditary retinoblastoma.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V – the vignette leads to a single best answer and the key matches it. Verdict: Correct best answer. The stem’s key discriminating features are: (1) bilateral hereditary retinoblastoma, (2) persistent class 3 vitreous seeds after systemic chemotherapy and three intravitreal melphalan injections, (3) tumor regression but diffuse non‑confluent vitreous opacities. These findings indicate refractory vitreous disease in a salvage‑eligible eye. Option D (intravitreal topotecan alternating with melphalan) is the preferred next step because it introduces a second agent with proven activity against melphalan‑resistant seeds while avoiding retinal toxicity from melphalan dose escalation. Options A (dose escalation) risks excess retinotoxicity without added benefit; B (plaque brachytherapy) is ineffective for diffuse seeds; C (enucleation) is premature when globe salvage is feasible; and E (external beam radiation) carries unacceptable late‑effect risk in hereditary disease. The rationale’s claim of 85 % salvage versus 40 % with continued melphalan aligns with published series, though the exact alternating schedule is institution‑specific. The only minor flaw is the phrase \\\"definitive management step,\\\" which could be misread; changing it to \\\"next management step\\\" would remove ambiguity. No medical inaccuracies are present. Score: 4.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V – the vignette leads to a single best answer and the key matches it. Verdict: Correct best answer. The stem’s key discriminating features are: (1) bilateral hereditary retinoblastoma, (2) persistent class 3 vitreous seeds after systemic chemotherapy and three intravitreal melphalan injections, (3) tumor regression but diffuse non‑confluent vitreous opacities. These findings indicate refractory vitreous disease in a salvage‑eligible eye. Option D (intravitreal topotecan alternating with melphalan) is the preferred next step because it introduces a second agent with proven activity against melphalan‑resistant seeds while avoiding retinal toxicity from melphalan dose escalation. Options A (dose escalation) risks excess retinotoxicity without added benefit; B (plaque brachytherapy) is ineffective for diffuse seeds; C (enucleation) is premature when globe salvage is feasible; and E (external beam radiation) carries unacceptable late‑effect risk in hereditary disease. The rationale’s claim of 85 % salvage versus 40 % with continued melphalan aligns with published series, though the exact alternating schedule is institution‑specific. The only minor flaw is the phrase \"definitive management step,\" which could be misread; changing it to \"next management step\" would remove ambiguity. No medical inaccuracies are present. Score: 4.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-004", "question": "A 45-year-old recreational athlete presents 8 weeks after feeling a 'pop' in his knee. Examination reveals a chronic patellar tendon rupture with 7 cm retraction gap and inability to perform straight leg raise. MRI shows tendon degeneration but intact retinaculum. What is the optimal reconstruction technique?", "options": ["A) Primary repair with Krackow sutures and wire augmentation", "B) Ipsilateral hamstring autograft reconstruction through bone tunnels", "C) Contralateral bone-patellar tendon-bone autograft with interference screws", "D) Achilles tendon allograft with patellar bone block fixation", "E) Staged reconstruction: tendon lengthening first, then primary repair"], "answer": "C", "answer_index": 2, "explanation": "For chronic patellar tendon rupture with >6 cm gap, contralateral bone-patellar tendon-bone autograft provides optimal biomechanical strength and facilitates early mobilization. The graft's bone blocks allow secure interference screw fixation in patellar and tibial tunnels, restoring native tendon length and avoiding the quadriceps lag associated with hamstring or allograft reconstructions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem's 7 cm gap and 8-week chronicity definitively exclude primary repair (A) and staged reconstruction (E). Contralateral BPTB autograft (C) is superior to ipsilateral hamstring (B) because it preserves ipsilateral flexor strength and avoids graft-site morbidity in the operative knee. Compared to allograft (D), autograft offers superior biologic incorporation without disease transmission risk or cost concerns—critical for a 45-year-old recreational athlete. Key discriminating clues: chronic rupture, large retraction gap (>6 cm), extensor mechanism failure, and intact retinaculum (confirms isolated tendon rupture). Main logical issue: None; 'optimal' is defensible as C uniquely combines autograft benefits with ipsilateral knee preservation. Minor medical accuracy issue: Rationale overstates that C 'avoids quadriceps lag' better than other grafts, as lag primarily reflects tensioning and rehabilitation rather than graft source. Minimal fix: Rephrase rationale to emphasize autograft incorporation and contralateral knee preservation, and explicitly confirm contralateral knee is healthy.\",\"medical_accuracy_score\":   \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem's 7 cm gap and 8-week chronicity definitively exclude primary repair (A) and staged reconstruction (E). Contralateral BPTB autograft (C) is superior to ipsilateral hamstring (B) because it preserves ipsilateral flexor strength and avoids graft-site morbidity in the operative knee. Compared to allograft (D), autograft offers superior biologic incorporation without disease transmission risk or cost concerns—critical for a 45-year-old recreational athlete. Key discriminating clues: chronic rupture, large retraction gap (>6 cm), extensor mechanism failure, and intact retinaculum (confirms isolated tendon rupture). Main logical issue: None; 'optimal' is defensible as C uniquely combines autograft benefits with ipsilateral knee preservation. Minor medical accuracy issue: Rationale overstates that C 'avoids quadriceps lag' better than other grafts, as lag primarily reflects tensioning and rehabilitation rather than graft source. Minimal fix: Rephrase rationale to emphasize autograft incorporation and contralateral knee preservation, and explicitly confirm contralateral knee is healthy.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-005", "question": "A 28-year-old man presents 6 hours after penile trauma during intercourse. Examination reveals swelling, deformity, and blood at the meatus. Retrograde urethrogram shows extravasation at the bulbar urethra without contrast reaching the bladder. What is the definitive surgical management?", "options": ["A) Immediate exploration via circumferential subcoronal incision with primary urethral anastomosis", "B) Delayed reconstruction after 3 months with buccal mucosa graft urethroplasty", "C) Suprapubic catheter placement with conservative management", "D) Immediate exploration with urethral repair over catheter without anastomosis", "E) Endoscopic urethral realignment with catheter stenting"], "answer": "D", "answer_index": 3, "explanation": "Penile fracture with concomitant partial urethral injury requires immediate exploration via circumferential degloving incision. Most urethral injuries are partial disruptions that can be repaired primarily over a catheter without tension-free anastomosis, preserving urethral length. Formal graft urethroplasty is reserved for complete transections or delayed presentations, while endoscopic management misses associated corporal injuries.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer D is not the best answer. The stem describes a penile fracture with blood at the meatus and a retrograde urethrogram showing extravasation at the bulbar urethra without contrast reaching the bladder—a classic finding of a complete urethral transection. Current urologic standards recommend immediate surgical exploration with primary urethral anastomosis (Option A) for acute complete disruptions. Option D (repair over catheter without anastomosis) is appropriate only for partial injuries, which the imaging does not support. The answer explanation incorrectly assumes a partial tear and ignores the imaging, leading to a miskeyed item. No internal contradictions exist, and the options allow clear discrimination, but the key does not match the unique best answer. Minimal fix: Change the key to A and revise the rationale to state that a complete bulbar urethral transection on retrograde urethrogram requires immediate exploration and primary anastomosis in the acute setting.\",\n\"medical_accuracy_score\":  \t \t \t \t \t \t\"2\",\n\"logical_validity\": false,\n\"logical_false_reason\": \"K\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer D is not the best answer. The stem describes a penile fracture with blood at the meatus and a retrograde urethrogram showing extravasation at the bulbar urethra without contrast reaching the bladder—a classic finding of a complete urethral transection. Current urologic standards recommend immediate surgical exploration with primary urethral anastomosis (Option A) for acute complete disruptions. Option D (repair over catheter without anastomosis) is appropriate only for partial injuries, which the imaging does not support. The answer explanation incorrectly assumes a partial tear and ignores the imaging, leading to a miskeyed item. No internal contradictions exist, and the options allow clear discrimination, but the key does not match the unique best answer. Minimal fix: Change the key to A and revise the rationale to state that a complete bulbar urethral transection on retrograde urethrogram requires immediate exploration and primary anastomosis in the acute setting.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-006", "question": "A 52-year-old woman develops clear rhinorrhea 3 days after endoscopic sinus surgery for revision frontal sinusitis. Intraoperative findings showed a 3 mm defect in the posterior table of the right frontal sinus. What is the optimal reconstruction method?", "options": ["A) Nasoseptal flap pedicled on posterior septal artery", "B) Middle turbinate flap with preservation of conchal crest attachment", "C) Free mucosal graft from inferior turbinate with tissue sealant", "D) Fat graft plugging with fascia lata overlay", "E) Synthetic dural substitute with fibrin glue"], "answer": "B", "answer_index": 1, "explanation": "For posterior table frontal sinus defects, the middle turbinate flap provides superior reach and vascularity compared to nasoseptal flaps. Preserving the conchal crest attachment maintains the axial blood supply from the sphenopalatine artery, ensuring graft survival in the poorly vascularized frontal sinus. Free grafts and synthetic materials have high failure rates in this location due to gravitational stress and limited recipient bed vascularity.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem presents a 52‑year‑old with clear rhinorrhea after revision frontal sinus surgery, indicating a CSF leak from a 3 mm posterior‑table defect. The key discriminating clue is the small but dependent frontal‑sinus defect that requires a vascularized flap for reliable closure. The middle‑turbinate flap (B) preserves the conchal‑crest attachment, maintaining axial blood flow from the sphenopalatine artery, providing robust vascularity and adequate reach to the posterior table. Alternative options are less suitable: the nasoseptal flap (A) has a shorter pedicle for this location; free grafts (C) and synthetic materials (E) lack vascularity and are prone to failure in a dependent sinus; fat‑fascia grafts (D) are more invasive. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy aligns with current endoscopic skull‑base reconstruction literature, which favors vascularized pedicled flaps for posterior‑table frontal‑sinus leaks. No changes are required; the item is board‑style valid.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem presents a 52‑year‑old with clear rhinorrhea after revision frontal sinus surgery, indicating a CSF leak from a 3 mm posterior‑table defect. The key discriminating clue is the small but dependent frontal‑sinus defect that requires a vascularized flap for reliable closure. The middle‑turbinate flap (B) preserves the conchal‑crest attachment, maintaining axial blood flow from the sphenopalatine artery, providing robust vascularity and adequate reach to the posterior table. Alternative options are less suitable: the nasoseptal flap (A) has a shorter pedicle for this location; free grafts (C) and synthetic materials (E) lack vascularity and are prone to failure in a dependent sinus; fat‑fascia grafts (D) are more invasive. No internal contradictions exist, and the options permit clear discrimination. Medical accuracy aligns with current endoscopic skull‑base reconstruction literature, which favors vascularized pedicled flaps for posterior‑table frontal‑sinus leaks. No changes are required; the item is board‑style valid.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-007", "question": "A 62-year-old man with left hemiplegia 4 months post-stroke has severe shoulder pain and 2 cm inferior subluxation on exam. EMG shows spastic co-contraction of posterior deltoid and supraspinatus without voluntary motor unit recruitment. What is the optimal botulinum toxin injection protocol?", "options": ["A) 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus", "B) 200 units onabotulinumtoxinA injected into subscapularis and pectoralis major only", "C) 50 units abobotulinumtoxinA into supraspinatus with ultrasound guidance", "D) 150 units incobotulinumtoxinA into posterior deltoid, supraspinatus, and upper trapezius", "E) 75 units onabotulinumtoxinA into posterior deltoid only"], "answer": "A", "answer_index": 0, "explanation": "For spasticity-driven post-stroke shoulder pain with subluxation, EMG-guided injection of 100 units incobotulinumtoxinA divided between posterior deltoid and supraspinatus reduces painful co-contraction while preserving anterior deltoid function for shoulder flexion. Targeting only internal rotators (subscapularis/pectoralis) worsens subluxation, and higher doses cause excessive weakness. The 1:1 conversion ratio of incobotulinumtoxinA provides predictable effect duration.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V. Verdict: The keyed answer A is the correct best choice. The stem provides clear discriminators: EMG-confirmed spastic co-contraction of posterior deltoid and supraspinatus, inferior subluxation, and severe pain after stroke. These findings indicate that the painful spastic muscles are the posterior deltoid and supraspinatus, while anterior deltoid function should be preserved for shoulder flexion. Option A uniquely addresses both spastic muscles with a total dose of 100 units of incobotulinumtoxinA, which is within the typical range for these muscles (≈25–50 U each) and respects the 1:1 dose equivalence with onabotulinumtoxinA, offering predictable duration. Alternatives are inferior: B targets non-spastic internal rotators (subscapularis/pectoralis) with a higher dose that could worsen subluxation; C underdoses a single muscle and uses abobotulinumtoxinA with a less favorable conversion; D adds an unnecessary upper trapezius target and increases total dose; E omits the supraspinatus component. No internal contradictions or missing critical details prevent a single best answer. The medical content aligns with contemporary spasticity management guidelines and dosing recommendations. Minimal fix: None required.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: The keyed answer A is the correct best choice. The stem provides clear discriminators: EMG-confirmed spastic co-contraction of posterior deltoid and supraspinatus, inferior subluxation, and severe pain after stroke. These findings indicate that the painful spastic muscles are the posterior deltoid and supraspinatus, while anterior deltoid function should be preserved for shoulder flexion. Option A uniquely addresses both spastic muscles with a total dose of 100 units of incobotulinumtoxinA, which is within the typical range for these muscles (≈25–50 U each) and respects the 1:1 dose equivalence with onabotulinumtoxinA, offering predictable duration. Alternatives are inferior: B targets non-spastic internal rotators (subscapularis/pectoralis) with a higher dose that could worsen subluxation; C underdoses a single muscle and uses abobotulinumtoxinA with a less favorable conversion; D adds an unnecessary upper trapezius target and increases total dose; E omits the supraspinatus component. No internal contradictions or missing critical details prevent a single best answer. The medical content aligns with contemporary spasticity management guidelines and dosing recommendations. Minimal fix: None required.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-008", "question": "A 71-year-old man with history of scalp radiation for basal cell carcinoma 20 years ago develops a 5 cm recurrent tumor with 2 cm calvarial erosion. After oncologic resection, there is a full-thickness calvarial defect with dural exposure. What is the optimal reconstruction?", "options": ["A) Latissimus dorsi myocutaneous free flap with split-thickness skin graft", "B) Omental free flap with vascularized bone graft", "C) Pericranial flap rotation with split calvarial graft", "D) Latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty", "E) Anterolateral thigh fasciocutaneous flap with titanium mesh"], "answer": "D", "answer_index": 3, "explanation": "In irradiated scalp defects with calvarial exposure, muscle-only free flaps (latissimus dorsi) provide robust vascularity to compromised beds while allowing secondary skin grafting. The muscle conforms better to calvarial contours than fasciocutaneous flaps, and delayed cranioplasty after soft tissue healing reduces hardware exposure risk. Myocutaneous flaps are too bulky, and local pericranial flaps have unreliable vascularity in previously irradiated fields.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues: 71-year-old, prior scalp radiation 20 years ago (fibrosis, compromised vascularity), 5 cm recurrent tumor, 2 cm calvarial erosion, full-thickness calvarial defect with dural exposure. These features mandate robust, reliable, well-vascularized coverage. The keyed answer D (latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty) is optimal because muscle flaps deliver superior blood flow to irradiated recipient beds, their pliability ensures better conformation to calvarial contours than fasciocutaneous alternatives, and staged cranioplasty after soft-tissue healing minimizes hardware exposure risk in a compromised wound. Option A is suboptimal due to myocutaneous flap bulk and contour irregularity. Option B is non-standard and overly complex. Option C is unreliable as radiation impairs local pericranial flap perfusion. Option E provides less robust vascularity and implies immediate titanium mesh placement, increasing infection/exposure risk in this high-risk setting. No logical contradictions or ambiguities exist. Medical content accurately reflects contemporary oncologic scalp reconstruction principles. Minimal fix: None required; item is board-examination ready.\",\"medical_accuracy_score\":  \"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: 71-year-old, prior scalp radiation 20 years ago (fibrosis, compromised vascularity), 5 cm recurrent tumor, 2 cm calvarial erosion, full-thickness calvarial defect with dural exposure. These features mandate robust, reliable, well-vascularized coverage. The keyed answer D (latissimus dorsi muscle-only free flap with skin graft and delayed cranioplasty) is optimal because muscle flaps deliver superior blood flow to irradiated recipient beds, their pliability ensures better conformation to calvarial contours than fasciocutaneous alternatives, and staged cranioplasty after soft-tissue healing minimizes hardware exposure risk in a compromised wound. Option A is suboptimal due to myocutaneous flap bulk and contour irregularity. Option B is non-standard and overly complex. Option C is unreliable as radiation impairs local pericranial flap perfusion. Option E provides less robust vascularity and implies immediate titanium mesh placement, increasing infection/exposure risk in this high-risk setting. No logical contradictions or ambiguities exist. Medical content accurately reflects contemporary oncologic scalp reconstruction principles. Minimal fix: None required; item is board-examination ready.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-009", "question": "A 28-year-old woman presents with progressive myelopathy over 6 months. MRI shows a holocord enhancing lesion from C2 to T9 with cystic components. Intraoperative neuromonitoring shows 60% amplitude reduction in motor evoked potentials after initial tumor debulking. What is the next surgical decision?", "options": ["A) Continue aggressive debulking despite signal changes", "B) Halt resection, perform duraplasty, and plan staged resection", "C) Switch to ultrasonic aspiration for gentler tumor removal", "D) Administer high-dose steroids and continue resection", "E) Perform en bloc resection of involved cord segments"], "answer": "B", "answer_index": 1, "explanation": "For holocord ependymoma, intraoperative neuromonitoring with >50% MEP amplitude reduction mandates immediate cessation of resection to prevent permanent neurologic deficit. Staged resection after allowing neural recovery (typically 3-6 months) achieves maximal safe cytoreduction. Continuing despite signal loss causes paraplegia, while en bloc resection is contraindicated in holocord lesions. Ultrasonic aspiration still transmits vibratory injury to compressed neural tissue.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The stem's critical discriminator is 60% MEP amplitude reduction after initial debulking of a holocord lesion, which exceeds the widely accepted >50% threshold mandating immediate cessation of resection to prevent permanent neurological injury. Keyed answer B correctly implements standard neurosurgical practice: halt resection, perform duraplasty for cord decompression, and plan staged resection after 3-6 months of neural recovery. Alternative A would likely cause paraplegia; C transmits vibratory injury to compressed tissue; D cannot acutely reverse ischemic signal loss; E is contraindicated for holocord extent. No logical flaws exist: the item presents a single, unambiguous best answer with appropriate option discrimination. Medical accuracy is gold-standard, reflecting current intraoperative neuromonitoring consensus and safe cytoreduction principles for extensive intramedullary tumors. Minimal fix: explicitly state 'intramedullary ependymoma' in the stem to eliminate minor ambiguity about tumor histology, though the monitoring principle applies regardless of pathology.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem's critical discriminator is 60% MEP amplitude reduction after initial debulking of a holocord lesion, which exceeds the widely accepted >50% threshold mandating immediate cessation of resection to prevent permanent neurological injury. Keyed answer B correctly implements standard neurosurgical practice: halt resection, perform duraplasty for cord decompression, and plan staged resection after 3-6 months of neural recovery. Alternative A would likely cause paraplegia; C transmits vibratory injury to compressed tissue; D cannot acutely reverse ischemic signal loss; E is contraindicated for holocord extent. No logical flaws exist: the item presents a single, unambiguous best answer with appropriate option discrimination. Medical accuracy is gold-standard, reflecting current intraoperative neuromonitoring consensus and safe cytoreduction principles for extensive intramedullary tumors. Minimal fix: explicitly state 'intramedullary ependymoma' in the stem to eliminate minor ambiguity about tumor histology, though the monitoring principle applies regardless of pathology.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-010", "question": "A 35-year-old woman is diagnosed with WNT-activated medulloblastoma after gross total resection. Molecular profiling shows CTNNB1 mutation without TP53 alteration. What is the recommended craniospinal irradiation dose and chemotherapy approach?", "options": ["A) 36 Gy craniospinal with posterior fossa boost to 54 Gy plus adjuvant temozolomide", "B) 23.4 Gy craniospinal with boost to 54 Gy, no chemotherapy", "C) 30.6 Gy craniospinal with boost to 55.8 Gy plus concurrent vincristine", "D) 18 Gy craniospinal with boost to 50.4 Gy plus high-dose chemotherapy with stem cell rescue", "E) 36 Gy craniospinal with boost to 55.8 Gy plus cisplatin-based chemotherapy"], "answer": "B", "answer_index": 1, "explanation": "WNT-activated medulloblastoma in adults has >95% 5-year survival, allowing significant craniospinal dose de-escalation to 23.4 Gy with posterior fossa boost to 54 Gy while omitting chemotherapy, reducing neurocognitive and endocrine toxicity. This protocol is supported by COG ACNS1422 and SJMB12 trials. Standard doses cause unnecessary toxicity, and chemotherapy adds no survival benefit in this molecular subgroup.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (multiple answers defensible). Verdict: Not uniquely determinable. Key stem clues: 35‑year‑old woman, gross total resection, WNT‑activated medulloblastoma with CTNNB1 mutation and no TP53 alteration. The stem does not state metastatic status or risk group; WNT‑activated disease is generally low‑risk, but adult management is not standardized. The answer B (23.4 Gy CSI, boost to 54 Gy, no chemotherapy) reflects a pediatric de‑escalation approach, but the cited COG ACNS1422 and SJMB12 trials actually include cisplatin‑based chemotherapy, creating a contradiction. Option E (36 Gy CSI, boost to 55.8 Gy, cisplatin‑based chemotherapy) represents the standard high‑risk regimen and is also plausible for a low‑risk adult, making both B and E defensible. Thus, the item fails to yield a single best answer. Medical accuracy: omission of chemotherapy is not standard and misrepresents trial data, constituting a major inaccuracy. Minimal fix: revise the answer to E, or explicitly state that the patient is on a de‑escalation protocol that omits chemotherapy, and update the explanation to reflect current evidence.\",\"medical_accuracy_score\":    \t\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (multiple answers defensible). Verdict: Not uniquely determinable. Key stem clues: 35‑year‑old woman, gross total resection, WNT‑activated medulloblastoma with CTNNB1 mutation and no TP53 alteration. The stem does not state metastatic status or risk group; WNT‑activated disease is generally low‑risk, but adult management is not standardized. The answer B (23.4 Gy CSI, boost to 54 Gy, no chemotherapy) reflects a pediatric de‑escalation approach, but the cited COG ACNS1422 and SJMB12 trials actually include cisplatin‑based chemotherapy, creating a contradiction. Option E (36 Gy CSI, boost to 55.8 Gy, cisplatin‑based chemotherapy) represents the standard high‑risk regimen and is also plausible for a low‑risk adult, making both B and E defensible. Thus, the item fails to yield a single best answer. Medical accuracy: omission of chemotherapy is not standard and misrepresents trial data, constituting a major inaccuracy. Minimal fix: revise the answer to E, or explicitly state that the patient is on a de‑escalation protocol that omits chemotherapy, and update the explanation to reflect current evidence.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-011", "question": "A 58-year-old man with mid-rectal cancer (cT3N1M0) has enlarged right obturator lymph node (8 mm) on staging MRI. The primary tumor is 5 cm from the anal verge. What is the optimal treatment sequence?", "options": ["A) Long-course chemoradiation (50.4 Gy) followed by total mesorectal excision without lateral dissection", "B) Short-course radiation (25 Gy) followed by extended lymphadenectomy including obturator nodes", "C) Chemoradiation (50.4 Gy) with boost to obturator node, then TME with selective lateral dissection if node persists", "D) Induction chemotherapy (FOLFOX) followed by chemoradiation and TME", "E) Total neoadjuvant therapy with consolidation chemotherapy then TME with bilateral lateral lymph node dissection"], "answer": "C", "answer_index": 2, "explanation": "For rectal cancer with suspicious lateral lymph node, chemoradiation with simultaneous integrated boost (60 Gy to node) followed by TME with selective lateral dissection only for radiologically persistent nodes balances local control and morbidity. Prophylactic lateral dissection causes unnecessary urinary and sexual dysfunction. The Japanese JCOG0212 trial showed selective dissection is non-inferior to routine dissection when nodes respond to radiation.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues: mid-rectal cT3N1M0 cancer with 8 mm right obturator lymph node (suspicious lateral pelvic node). Standard management requires neoadjuvant chemoradiation; presence of lateral node warrants radiation boost and consideration of selective lateral lymph node dissection (LLND). Option C uniquely addresses this with chemoradiation + node boost followed by TME with selective LLND if node persists. Alternatives are inferior: A ignores lateral node risk; B uses short-course radiation (less effective for nodal downstaging) and mandates extended dissection; D adds unnecessary induction chemotherapy delay; E mandates bilateral LLND (excessive morbidity for unilateral disease). No logical issues: stem is specific, options discriminate clearly, and key is supported. Medical accuracy: aligns with NCCN/ESMO guidelines and evidence (JCOG0212 principle of selective dissection, though trial enrolled node-negative patients; JCOG1316 more directly supports selective approach). Rationale correctly notes morbidity avoidance. Minor nuance: boost dose typically 56-60 Gy, not always 60 Gy, but principle is sound. Minimal fix: specify boost dose range (e.g., 56-60 Gy) and clarify that selective dissection is based on post-treatment imaging to enhance precision.\",\"medical_accuracy_score\":  \t\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues: mid-rectal cT3N1M0 cancer with 8 mm right obturator lymph node (suspicious lateral pelvic node). Standard management requires neoadjuvant chemoradiation; presence of lateral node warrants radiation boost and consideration of selective lateral lymph node dissection (LLND). Option C uniquely addresses this with chemoradiation + node boost followed by TME with selective LLND if node persists. Alternatives are inferior: A ignores lateral node risk; B uses short-course radiation (less effective for nodal downstaging) and mandates extended dissection; D adds unnecessary induction chemotherapy delay; E mandates bilateral LLND (excessive morbidity for unilateral disease). No logical issues: stem is specific, options discriminate clearly, and key is supported. Medical accuracy: aligns with NCCN/ESMO guidelines and evidence (JCOG0212 principle of selective dissection, though trial enrolled node-negative patients; JCOG1316 more directly supports selective approach). Rationale correctly notes morbidity avoidance. Minor nuance: boost dose typically 56-60 Gy, not always 60 Gy, but principle is sound. Minimal fix: specify boost dose range (e.g., 56-60 Gy) and clarify that selective dissection is based on post-treatment imaging to enhance precision.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-012", "question": "A 6-year-old child has a retroperitoneal lymphangioma extending from renal hilum to pelvis, causing refractory chylous ascites requiring weekly paracentesis. Imaging shows a multiloculated cystic mass with thin septations. What is the definitive management?", "options": ["A) Complete surgical excision via retroperitoneal approach", "B) Percutaneous sclerotherapy with doxycycline and ethanol", "C) Laparoscopic fenestration and omental marsupialization", "D) Observation with medium-chain triglyceride diet", "E) Retroperitoneal lymph node dissection with lymphatic ligation"], "answer": "B", "answer_index": 1, "explanation": "Large retroperitoneal lymphangiomas with chylous ascites are best managed with percutaneous sclerotherapy using doxycycline and ethanol, achieving 85% cure rate. The multiloculated nature makes complete surgical excision hazardous due to proximity to renal vessels and pancreas, with 40% recurrence and high morbidity. Sclerotherapy induces fibrosis of lymphatic channels while preserving adjacent structures, and is superior to laparoscopic fenestration for macrocystic lesions.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). Verdict: Correct best answer. The stem provides key discriminating findings: a large, multiloculated, macrocystic retroperitoneal lymphangioma causing refractory chylous ascites requiring weekly paracentesis. These features favor a minimally invasive sclerotherapy approach over surgery. The location (renal hilum to pelvis) implies proximity to vital structures, making complete excision hazardous. The keyed answer B (percutaneous sclerotherapy with doxycycline and ethanol) aligns with current consensus that sclerotherapy is first-line for macrocystic lymphatic malformations, offering high cure rates (≈85%) while preserving adjacent organs. Alternative options are less appropriate: A (complete excision) carries high morbidity and recurrence; C (laparoscopic fenestration) is less effective for multiloculated lesions; D (observation) is insufficient for refractory ascites; E (lymph node dissection) is not indicated. No internal contradictions or missing details prevent a unique best answer. Medical accuracy is high; the rationale reflects contemporary practice and published success rates. Minimal fix: explicitly state that complete surgical excision is high risk due to proximity to renal vessels and pancreas, reinforcing the rationale for sclerotherapy.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). Verdict: Correct best answer. The stem provides key discriminating findings: a large, multiloculated, macrocystic retroperitoneal lymphangioma causing refractory chylous ascites requiring weekly paracentesis. These features favor a minimally invasive sclerotherapy approach over surgery. The location (renal hilum to pelvis) implies proximity to vital structures, making complete excision hazardous. The keyed answer B (percutaneous sclerotherapy with doxycycline and ethanol) aligns with current consensus that sclerotherapy is first-line for macrocystic lymphatic malformations, offering high cure rates (≈85%) while preserving adjacent organs. Alternative options are less appropriate: A (complete excision) carries high morbidity and recurrence; C (laparoscopic fenestration) is less effective for multiloculated lesions; D (observation) is insufficient for refractory ascites; E (lymph node dissection) is not indicated. No internal contradictions or missing details prevent a unique best answer. Medical accuracy is high; the rationale reflects contemporary practice and published success rates. Minimal fix: explicitly state that complete surgical excision is high risk due to proximity to renal vessels and pancreas, reinforcing the rationale for sclerotherapy.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-013", "question": "A 67-year-old man has ocular surface squamous neoplasia involving 5 clock hours of limbus with anterior segment OCT showing 1.2 mm depth of invasion into peripheral cornea. There is no scleral invasion. What is the management?", "options": ["A) Enucleation with orbital implant", "B) Exenteration with adjuvant radiation therapy", "C) Globe-sparing tumor excision with lamellar keratoplasty and adjuvant plaque brachytherapy", "D) Topical interferon alpha-2b for 6 months", "E) Cryotherapy to tumor base with amniotic membrane transplantation"], "answer": "C", "answer_index": 2, "explanation": "Ocular surface squamous neoplasia with intraocular invasion <2 mm depth can be managed with globe-sparing lamellar keratoplasty to clear margins followed by adjuvant strontium-90 plaque brachytherapy (30 Gy to base). This achieves 90% local control while preserving vision. Enucleation is reserved for scleral invasion or recurrence. Topical therapy cannot penetrate intraocular extension, and cryotherapy alone is insufficient for invasive disease.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). The stem provides sufficient discriminating detail to select a single best answer. Key clues are: ocular surface squamous neoplasia with 1.2 mm corneal stromal invasion, absence of scleral invasion, and 5 clock hours of limbal involvement. These features define invasive disease amenable to globe-sparing therapy. The keyed answer C (globe-sparing excision with lamellar keratoplasty and plaque brachytherapy) is defensible as the unique best choice because it addresses both the corneal invasion (via lamellar keratoplasty) and the risk of recurrence (via adjuvant brachytherapy). Alternative A (enucleation) and B (exenteration) are overly aggressive for disease without scleral invasion. Option D (topical interferon) is ineffective for intraocular extension >1 mm. Option E (cryotherapy with amniotic membrane) is insufficient for invasive disease. No internal contradictions exist. Medical accuracy is high: current ophthalmic oncology guidelines support globe-sparing surgery with adjuvant brachytherapy for corneal invasion <2 mm without scleral involvement, achieving excellent local control. The rationale correctly identifies that topical therapy cannot penetrate deep stromal disease. Minimal fix: none required; item is board-ready.\",\"medical_accuracy_score\":   \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The stem provides sufficient discriminating detail to select a single best answer. Key clues are: ocular surface squamous neoplasia with 1.2 mm corneal stromal invasion, absence of scleral invasion, and 5 clock hours of limbal involvement. These features define invasive disease amenable to globe-sparing therapy. The keyed answer C (globe-sparing excision with lamellar keratoplasty and plaque brachytherapy) is defensible as the unique best choice because it addresses both the corneal invasion (via lamellar keratoplasty) and the risk of recurrence (via adjuvant brachytherapy). Alternative A (enucleation) and B (exenteration) are overly aggressive for disease without scleral invasion. Option D (topical interferon) is ineffective for intraocular extension >1 mm. Option E (cryotherapy with amniotic membrane) is insufficient for invasive disease. No internal contradictions exist. Medical accuracy is high: current ophthalmic oncology guidelines support globe-sparing surgery with adjuvant brachytherapy for corneal invasion <2 mm without scleral involvement, achieving excellent local control. The rationale correctly identifies that topical therapy cannot penetrate deep stromal disease. Minimal fix: none required; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-014", "question": "A 78-year-old woman falls and sustains a four-part proximal humerus fracture with head-split pattern and 2 cm medial calcar comminution. The greater tuberosity is fractured but not displaced. What is the optimal implant selection?", "options": ["A) Open reduction and internal fixation with locking plate and fibular allograft augmentation", "B) Hemiarthroplasty with cemented stem and tuberosity repair", "C) Reverse shoulder arthroplasty with 36 mm glenosphere and augmented baseplate", "D) Reverse shoulder arthroplasty with standard baseplate and tuberosity preservation", "E) Nonoperative management with sling and early passive motion"], "answer": "D", "answer_index": 3, "explanation": "In elderly patients with head-split fractures and intact tuberosities, reverse shoulder arthroplasty with standard baseplate and tuberosity preservation (not repair) provides superior forward elevation and reduces prosthetic instability. Augmented baseplates are unnecessary without glenoid bone loss, and tuberosity repair in reverse arthroplasty increases stiffness without functional benefit. ORIF has 60% failure rate in this pattern, and hemiarthroplasty requires functional rotator cuff.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Orthopedic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. This 78-year-old with a four-part head-split proximal humerus fracture and medial calcar comminution represents a classic indication for reverse shoulder arthroplasty (RSA) due to high risk of osteonecrosis and fixation failure. Key discriminating findings are advanced age, head-split pattern, and medial comminution, all predicting poor outcomes with ORIF (Option A) or hemiarthroplasty (Option B). Nonoperative management (E) is inappropriate. Between RSA options, the absence of stated glenoid bone loss makes a standard baseplate (D) preferable to an augmented baseplate (C). The keyed answer is defensible as the most contemporary standard: RSA provides reliable pain relief and forward elevation in elderly fracture patients. Medical accuracy is downgraded to 3 because the rationale's claim that 'tuberosity preservation provides superior forward elevation' and 'tuberosity repair increases stiffness without functional benefit' reflects a specific surgical philosophy rather than established consensus; many surgeons repair non-displaced tuberosities to improve external rotation. The item remains logically valid as D is uniquely best among options. Minimal fix: Revise option D to 'Reverse shoulder arthroplasty with standard baseplate' and adjust rationale to state that tuberosity management should be individualized, with preservation acceptable for non-displaced fragments.\",\"medical_accuracy_score\":   \"3\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. This 78-year-old with a four-part head-split proximal humerus fracture and medial calcar comminution represents a classic indication for reverse shoulder arthroplasty (RSA) due to high risk of osteonecrosis and fixation failure. Key discriminating findings are advanced age, head-split pattern, and medial comminution, all predicting poor outcomes with ORIF (Option A) or hemiarthroplasty (Option B). Nonoperative management (E) is inappropriate. Between RSA options, the absence of stated glenoid bone loss makes a standard baseplate (D) preferable to an augmented baseplate (C). The keyed answer is defensible as the most contemporary standard: RSA provides reliable pain relief and forward elevation in elderly fracture patients. Medical accuracy is downgraded to 3 because the rationale's claim that 'tuberosity preservation provides superior forward elevation' and 'tuberosity repair increases stiffness without functional benefit' reflects a specific surgical philosophy rather than established consensus; many surgeons repair non-displaced tuberosities to improve external rotation. The item remains logically valid as D is uniquely best among options. Minimal fix: Revise option D to 'Reverse shoulder arthroplasty with standard baseplate' and adjust rationale to state that tuberosity management should be individualized, with preservation acceptable for non-displaced fragments.", "medical_accuracy_score": 3, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-015", "question": "A 42-year-old woman has a 3 cm proximal urethral diverticulum containing multiple calculi on MRI. She has recurrent urinary tract infections and post-void dribbling. What is the optimal surgical approach?", "options": ["A) Transvaginal diverticulectomy with urethral reconstruction and stone extraction", "B) Endoscopic unroofing with laser lithotripsy of calculi", "C) Transvaginal marsupialization with stone extraction and layered closure", "D) Urethral dilation and transurethral stone extraction", "E) Laparoscopic diverticulectomy with robotic assistance"], "answer": "C", "answer_index": 2, "explanation": "Proximal urethral diverticulum with calculi is best managed via transvaginal marsupialization with complete stone extraction and multilayered closure (urethra, periurethral fascia, vaginal wall). This preserves urethral length and continence while eliminating the stone-bearing cavity. Formal diverticulectomy risks urethral stricture and incontinence. Endoscopic unroofing is inadequate for proximal lesions and leaves stone fragments. Laparoscopic approach offers no advantage for this extraperitoneal pathology.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Urology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. The stem presents a 42-year-old woman with a symptomatic, 3 cm proximal urethral diverticulum containing multiple calculi. The critical discriminating features are the proximal location and stone burden, which directly inform surgical approach. Transvaginal marsupialization with stone extraction and layered closure (C) is the optimal choice as it preserves urethral length, minimizes sphincter injury, and maintains continence while completely eradicating the stone-bearing cavity. Alternative A (formal diverticulectomy) carries excessive risk of urethral stricture and incontinence for proximal lesions. Option B (endoscopic unroofing) is poorly suited for proximal diverticula and risks incomplete stone clearance. Option D addresses only stones while ignoring the diverticulum. Option E is not indicated for extraperitoneal pathology. The item is well-specified with no critical omissions, and options are distinct and permit clear discrimination. The keyed answer reflects current urogynecology consensus. No medical inaccuracies or logical flaws identified. Minimal fix: none required.\",\"medical_accuracy_score\":   \"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. The stem presents a 42-year-old woman with a symptomatic, 3 cm proximal urethral diverticulum containing multiple calculi. The critical discriminating features are the proximal location and stone burden, which directly inform surgical approach. Transvaginal marsupialization with stone extraction and layered closure (C) is the optimal choice as it preserves urethral length, minimizes sphincter injury, and maintains continence while completely eradicating the stone-bearing cavity. Alternative A (formal diverticulectomy) carries excessive risk of urethral stricture and incontinence for proximal lesions. Option B (endoscopic unroofing) is poorly suited for proximal diverticula and risks incomplete stone clearance. Option D addresses only stones while ignoring the diverticulum. Option E is not indicated for extraperitoneal pathology. The item is well-specified with no critical omissions, and options are distinct and permit clear discrimination. The keyed answer reflects current urogynecology consensus. No medical inaccuracies or logical flaws identified. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-016", "question": "A 55-year-old man has left vocal fold paralysis 6 months after thyroidectomy, with persistent aspiration and breathy voice. EMG shows absent motor unit potentials. What is the optimal injection laryngoplasty material?", "options": ["A) Hyaluronic acid gel for temporary medialization", "B) Calcium hydroxylapatite paste for permanent augmentation", "C) Autologous fat injection for long-term volume restoration", "D) Gelfoam paste for temporary 3-month effect", "E) Polydimethylsiloxane for permanent irreversible medialization"], "answer": "B", "answer_index": 1, "explanation": "For permanent vocal fold paralysis with absent EMG potentials, calcium hydroxylapatite provides durable medialization without migration. Its high viscosity prevents particle dispersion, and it integrates into tissue without foreign body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat has unpredictable resorption (50-80% at 1 year), and polydimethylsiloxane risks granuloma formation and airway compromise if overinjected.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Otolaryngology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer B (calcium hydroxylapatite) is the correct best answer. The stem provides clear discriminating clues: persistent aspiration and breathy voice 6 months after thyroidectomy, plus absent motor unit potentials on EMG, indicating a permanent recurrent laryngeal nerve injury. These findings establish the need for a durable, permanent medialization material. Among the options, calcium hydroxylapatite is the only permanent filler with proven long-term stability, low migration risk, and minimal foreign-body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat suffers from unpredictable resorption (50–80% at 1 year), and polydimethylsiloxane carries a higher risk of granuloma formation and airway compromise. Therefore, a single best answer is defensible, and the key matches it. No internal contradictions or missing critical details are present. Medical accuracy is high: the explanation aligns with current laryngology guidelines and the literature on injection laryngoplasty. Minor nuance: some surgeons may consider fat grafting in selected cases, but the question asks for the ‘optimal’ material, making calcium hydroxylapatite the preferred choice. Minimal fix: none required; the item is already precise.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer B (calcium hydroxylapatite) is the correct best answer. The stem provides clear discriminating clues: persistent aspiration and breathy voice 6 months after thyroidectomy, plus absent motor unit potentials on EMG, indicating a permanent recurrent laryngeal nerve injury. These findings establish the need for a durable, permanent medialization material. Among the options, calcium hydroxylapatite is the only permanent filler with proven long-term stability, low migration risk, and minimal foreign-body reaction. Hyaluronic acid and Gelfoam are temporary (<6 months) and unsuitable for permanent paralysis. Autologous fat suffers from unpredictable resorption (50–80% at 1 year), and polydimethylsiloxane carries a higher risk of granuloma formation and airway compromise. Therefore, a single best answer is defensible, and the key matches it. No internal contradictions or missing critical details are present. Medical accuracy is high: the explanation aligns with current laryngology guidelines and the literature on injection laryngoplasty. Minor nuance: some surgeons may consider fat grafting in selected cases, but the question asks for the ‘optimal’ material, making calcium hydroxylapatite the preferred choice. Minimal fix: none required; the item is already precise.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-017", "question": "A 45-year-old man with T6 complete spinal cord injury has a stage 4 sacral pressure ulcer with positive probe-to-bone test and MRI showing marrow edema limited to cortex. He has been on antibiotics for 4 weeks with minimal improvement. What is definitive management?", "options": ["A) Continue suppressive antibiotics indefinitely with wound care", "B) Surgical debridement to bone with burr drilling, VAC therapy, then gluteal myocutaneous flap", "C) Radical debridement with partial sacrectomy and omental flap", "D) Transcutaneous bone biopsy and targeted IV antibiotics for 12 weeks", "E) Osteomyelitis excision with free latissimus dorsi muscle flap"], "answer": "B", "answer_index": 1, "explanation": "Stage 4 sacral ulcer with cortical osteomyelitis requires surgical debridement with burr drilling of exposed bone to bleeding cortex, followed by VAC therapy to prepare granulation tissue, then gluteal myocutaneous flap coverage. This achieves 85% healing rates. Partial sacrectomy is reserved for medullary involvement. Suppressive antibiotics alone fail in 70% of cases, and free flaps are unnecessary when local muscle is available and viable.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Physical Medicine and Rehabilitation", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues drive a unique answer: stage 4 sacral pressure ulcer with exposed bone, positive probe-to-bone test, MRI-confirmed cortical osteomyelitis, failure of 4-week antibiotic trial, and T6 complete SCI (gluteal muscles remain innervated and viable). These findings mandate surgical debridement with local flap coverage. Option B precisely matches this: burr drilling addresses cortical disease, VAC therapy prepares the wound bed, and gluteal myocutaneous flap provides durable coverage using viable local tissue. Each distractor is validly inferior: A (suppressives fail ~70%), C (partial sacrectomy overtreats cortical involvement), D (biopsy/antibiotics alone insufficient for stage 4 ulcer), E (free flap unnecessarily complex when local muscle available). No internal contradictions or missing critical details. Medical accuracy is excellent: reflects current pressure ulcer guidelines and reconstructive principles distinguishing cortical vs medullary osteomyelitis, with appropriate flap selection based on muscle viability. Rationale's 85% healing rate is supported by literature. Minimal fix: None; item is board-exam ready.\",\"medical_accuracy_score\":  \"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues drive a unique answer: stage 4 sacral pressure ulcer with exposed bone, positive probe-to-bone test, MRI-confirmed cortical osteomyelitis, failure of 4-week antibiotic trial, and T6 complete SCI (gluteal muscles remain innervated and viable). These findings mandate surgical debridement with local flap coverage. Option B precisely matches this: burr drilling addresses cortical disease, VAC therapy prepares the wound bed, and gluteal myocutaneous flap provides durable coverage using viable local tissue. Each distractor is validly inferior: A (suppressives fail ~70%), C (partial sacrectomy overtreats cortical involvement), D (biopsy/antibiotics alone insufficient for stage 4 ulcer), E (free flap unnecessarily complex when local muscle available). No internal contradictions or missing critical details. Medical accuracy is excellent: reflects current pressure ulcer guidelines and reconstructive principles distinguishing cortical vs medullary osteomyelitis, with appropriate flap selection based on muscle viability. Rationale's 85% healing rate is supported by literature. Minimal fix: None; item is board-exam ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-018", "question": "A 35-year-old man sustains deep partial-thickness burns to both upper eyelids with early cicatricial ectropion and 3 mm scleral show. The tarsal plate is intact but contracted. What is the optimal reconstruction timing and technique?", "options": ["A) Immediate full-thickness skin graft from supraclavicular fossa with tarsorrhaphy", "B) Delayed reconstruction at 6 months with split-thickness skin graft and Frost suture", "C) Immediate Mustarde cheek advancement flap with cartilage graft", "D) Delayed full-thickness skin graft from postauricular area with tarsal release", "E) Immediate temporoparietal fascia flap with skin graft"], "answer": "D", "answer_index": 3, "explanation": "For post-burn eyelid ectropion with tarsal contracture, delayed reconstruction at 6-12 months with full-thickness postauricular skin graft after complete tarsal release provides optimal color match and prevents retraction. Immediate grafting fails due to ongoing inflammation and inadequate recipient bed vascularity. Mustarde flaps are excessive for isolated eyelid involvement, and temporoparietal fascia is reserved for total eyelid loss. Postauricular skin has thinner dermis than supraclavicular, better matching eyelid architecture.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Plastic Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: Correct best answer. The stem's key findings—deep partial-thickness burns with early cicatricial ectropion, 3 mm scleral show, and contracted but intact tarsal plate—establish a post-burn anterior lamellar contracture requiring definitive reconstruction. Option D uniquely integrates all critical principles: delayed timing (6-12 months) permits inflammation resolution and scar maturation essential for graft take; full-thickness postauricular skin graft provides superior color match and thin dermis ideal for eyelid architecture; tarsal release directly addresses the pathologic contracture. Each distractor is appropriately eliminated: A and C propose immediate reconstruction in a suboptimal inflammatory bed; A's supraclavicular donor has poor color match and excessive thickness; B's split-thickness graft risks recontracture and poor aesthetics; C's Mustarde flap is overkill for isolated eyelid involvement; E's temporoparietal fascia flap is indicated for total eyelid loss, not ectropion. No internal contradictions or critical missing details. Medical accuracy is excellent, reflecting current burn reconstruction and oculoplastic standards. The item tests high-yield principles of timing, graft selection, donor site choice, and flap indications. No revision needed.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem's key findings—deep partial-thickness burns with early cicatricial ectropion, 3 mm scleral show, and contracted but intact tarsal plate—establish a post-burn anterior lamellar contracture requiring definitive reconstruction. Option D uniquely integrates all critical principles: delayed timing (6-12 months) permits inflammation resolution and scar maturation essential for graft take; full-thickness postauricular skin graft provides superior color match and thin dermis ideal for eyelid architecture; tarsal release directly addresses the pathologic contracture. Each distractor is appropriately eliminated: A and C propose immediate reconstruction in a suboptimal inflammatory bed; A's supraclavicular donor has poor color match and excessive thickness; B's split-thickness graft risks recontracture and poor aesthetics; C's Mustarde flap is overkill for isolated eyelid involvement; E's temporoparietal fascia flap is indicated for total eyelid loss, not ectropion. No internal contradictions or critical missing details. Medical accuracy is excellent, reflecting current burn reconstruction and oculoplastic standards. The item tests high-yield principles of timing, graft selection, donor site choice, and flap indications. No revision needed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-019", "question": "A 12-year-old girl with Chiari I malformation and holocord syringomyelia undergoes posterior fossa decompression. Intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. What is the next step?", "options": ["A) Perform duraplasty with bovine pericardial graft and tonsillectomy", "B) Perform duraplasty with autologous pericranial graft without tonsillectomy", "C) Extend bone decompression to C2 without dural opening", "D) Perform tonsillectomy only without duraplasty", "E) Place syringosubarachnoid shunt"], "answer": "B", "answer_index": 1, "explanation": "When intraoperative ultrasound shows persistent syrinx after bone decompression, duraplasty with autologous pericranial graft restores normal CSF flow dynamics without tonsillectomy. Autologous graft reduces pseudomeningocele risk compared to allograft. Tonsillectomy adds morbidity without additional syrinx resolution when duraplasty alone achieves flow restoration. Syringosubarachnoid shunt is reserved for failed decompression, and extending bone removal is ineffective without addressing dural restriction.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurological Surgery", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (valid). Verdict: Correct best answer. Key stem clues: 12-year-old Chiari I with holocord syrinx, posterior fossa decompression performed, intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. This indicates that bone decompression alone has not restored CSF flow and that the dura is still restrictive. The next logical step is to open the dura and perform a duraplasty. The answer B (autologous pericranial graft without tonsillectomy) aligns with standard practice: autologous graft reduces infection and pseudomeningocele risk compared with allograft (e.g., bovine pericardium), and tonsillectomy is not required when pulsation suggests the tonsils are not adherent. Alternative options are less appropriate: A uses allograft and adds unnecessary tonsillectomy; C extends bone removal without addressing dural obstruction; D omits duraplasty; E reserves shunt for failed decompression. No internal contradictions; the vignette provides sufficient detail to select a single best answer. Medical accuracy: The item reflects current neurosurgical consensus on posterior fossa decompression for Chiari I–syringomyelia; the preference for autologous graft and selective tonsillectomy is well supported. Minor nuance: some surgeons may choose tonsillectomy in select cases, but the stem’s mention of tonsillar pulsation justifies omitting it. Score: 4. Minimal fix: none required.\",\n\"medical_accuracy_score\":   \t\"4\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). Verdict: Correct best answer. Key stem clues: 12-year-old Chiari I with holocord syrinx, posterior fossa decompression performed, intraoperative ultrasound after bone removal shows persistent syrinx with tonsillar pulsation. This indicates that bone decompression alone has not restored CSF flow and that the dura is still restrictive. The next logical step is to open the dura and perform a duraplasty. The answer B (autologous pericranial graft without tonsillectomy) aligns with standard practice: autologous graft reduces infection and pseudomeningocele risk compared with allograft (e.g., bovine pericardium), and tonsillectomy is not required when pulsation suggests the tonsils are not adherent. Alternative options are less appropriate: A uses allograft and adds unnecessary tonsillectomy; C extends bone removal without addressing dural obstruction; D omits duraplasty; E reserves shunt for failed decompression. No internal contradictions; the vignette provides sufficient detail to select a single best answer. Medical accuracy: The item reflects current neurosurgical consensus on posterior fossa decompression for Chiari I–syringomyelia; the preference for autologous graft and selective tonsillectomy is well supported. Minor nuance: some surgeons may choose tonsillectomy in select cases, but the stem’s mention of tonsillar pulsation justifies omitting it. Score: 4. Minimal fix: none required.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251221T010349114Z_kimi-k2-thinking_seed130", "question_id": "20251221T010349114Z_kimi-k2-thinking_seed130-020", "question": "A 62-year-old man with T2N0M0 glottic carcinoma involving the anterior commissure is scheduled for definitive radiation therapy. He has good performance status and no comorbidities. What is the optimal fractionation scheme to maximize local control?", "options": ["A) 70 Gy in 35 fractions over 7 weeks with concurrent cisplatin", "B) 66 Gy in 33 fractions over 6.5 weeks with concurrent cetuximab", "C) 72 Gy in 42 fractions using concomitant boost over 6 weeks", "D) 60 Gy in 30 fractions over 6 weeks with hyperfractionation", "E) 50 Gy in 20 fractions over 4 weeks with hypofractionation"], "answer": "C", "answer_index": 2, "explanation": "For T2 glottic cancer with anterior commissure involvement, altered fractionation with concomitant boost (72 Gy/42 fractions/6 weeks) improves 5-year local control to 85% versus 70% with standard fractionation, without increasing late toxicity. The anterior commissure is a sanctuary site with poor vascularity, requiring higher biologically effective dose. Concurrent chemotherapy is not indicated for T2 disease and increases mucositis. Hypofractionation is reserved for early T1 lesions without commissure involvement.", "generator_model": "kimi-k2-thinking", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Radiation Oncology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). The stem provides a clear clinical scenario: T2N0M0 glottic carcinoma with anterior commissure involvement, good PS, no comorbidities, seeking optimal RT fractionation to maximize local control. Key discriminating features are T2 stage and anterior commissure involvement, which are indications for altered fractionation. The keyed answer C (72 Gy/42 fractions concomitant boost) is the only option consistent with current NCCN guidelines for this scenario; it offers higher biologically effective dose without concurrent chemo, which is not indicated for T2 disease. Alternatives A and B add systemic therapy that is not standard for T2 glottic cancer. D is mislabeled hyperfractionation and underdosed. E is hypofractionation reserved for T1 lesions. Thus a single best answer is defensible and the key matches it. No internal contradictions or missing details. Medical accuracy: The concomitant boost regimen is supported by randomized data (RTOG 90‑03) and specialty guidelines; the statement that it improves local control without increasing late toxicity is largely accurate. No major errors. Minor nuance: absolute local‑control percentages may vary by series, but the teaching point remains valid. Minimal fix: none required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). The stem provides a clear clinical scenario: T2N0M0 glottic carcinoma with anterior commissure involvement, good PS, no comorbidities, seeking optimal RT fractionation to maximize local control. Key discriminating features are T2 stage and anterior commissure involvement, which are indications for altered fractionation. The keyed answer C (72 Gy/42 fractions concomitant boost) is the only option consistent with current NCCN guidelines for this scenario; it offers higher biologically effective dose without concurrent chemo, which is not indicated for T2 disease. Alternatives A and B add systemic therapy that is not standard for T2 glottic cancer. D is mislabeled hyperfractionation and underdosed. E is hypofractionation reserved for T1 lesions. Thus a single best answer is defensible and the key matches it. No internal contradictions or missing details. Medical accuracy: The concomitant boost regimen is supported by randomized data (RTOG 90‑03) and specialty guidelines; the statement that it improves local control without increasing late toxicity is largely accurate. No major errors. Minor nuance: absolute local‑control percentages may vary by series, but the teaching point remains valid. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]